Penicillin Allergy Clinical Trial
Official title:
The Optimized Diagnostic Methods for the Confirmation of Beta-lactam Hypersensitivity in Thailand
NCT number | NCT01667055 |
Other study ID # | Chula-ARC 002/12 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | June 2012 |
Est. completion date | December 2018 |
Verified date | October 2019 |
Source | Chulalongkorn University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The true prevalence of drug allergy in patients with a history of beta-lactam hypersensitivity will be determined by using commercially available standard skin test reagents and the diagnostic agents available in Thailand. We hypothesize that only minority of patients with such a history are truly allergic.
Status | Completed |
Enrollment | 500 |
Est. completion date | December 2018 |
Est. primary completion date | December 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 7 Years and older |
Eligibility |
Inclusion Criteria: - Patients with a history of beta-lactam hypersensitivity Exclusion Criteria: - Being pregnant - Having serious medical illnesses |
Country | Name | City | State |
---|---|---|---|
Thailand | Chulalongkorn University | Bangkok |
Lead Sponsor | Collaborator |
---|---|
Chulalongkorn University |
Thailand,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The true prevalence of drug allergy in patients with a history of beta-lactam hypersensitivity | The skin test positive rate in patients with a history of beta-lactam hypersensitivity | 1 year | |
Secondary | Clinical values of various diagnostic modalities in patients with a history of beta-lactam hypersensitivity | The diagnostic values of skin testing, drug-specific Immunoglobulin E measurement, and interferon-gamma ELISpot assay for the diagnosis of beta-lactam hypersensitivity | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT05563610 -
Oral Penicillin Challenge and Allergy De-labeling in Children
|
Phase 4 | |
Completed |
NCT05020327 -
Inpatient Penicillin Allergy Delabeling Study
|
Phase 4 | |
Completed |
NCT04441021 -
Feasibility Assessment of Risk Stratification and Oral Challenge in Hospitalized Children at Low Risk for Antibiotic Allergy
|
||
Not yet recruiting |
NCT05956080 -
Penicillin Allergy Delabeling Among Surgical Patients
|
N/A | |
Recruiting |
NCT03757052 -
Amoxicillin Challenge for Penicillin Allergy Diagnosis
|
N/A | |
Completed |
NCT03702270 -
The Effect of Providing Stratification of Low Risk Penicillin Allergies on Penicillin Allergy Label Removal
|
N/A | |
Recruiting |
NCT05464615 -
Geisinger Antibiotic Allergy Pilot Program: Assess and Address
|
Early Phase 1 | |
Completed |
NCT03702283 -
Effect of Providing Stratification of Low Risk Penicillin Allergies on Penicillin Allergy Label Removal in ICU Setting
|
N/A | |
Not yet recruiting |
NCT03499457 -
Penicillin Allergy in Shfayim Clinic
|
N/A | |
Withdrawn |
NCT00589251 -
Equivalency of Penicilloate Skin Test Reactivity Prepared by a Modified Alkaline Hydrolysis Technique
|
N/A | |
Completed |
NCT04620746 -
Penicillin Allergy Testing in STD Clinics
|
Phase 4 | |
Completed |
NCT05090527 -
Penicillin Allergy Delabeling Project
|
N/A | |
Completed |
NCT03033394 -
Beta-lactam Pharmacokinetics in Secondary Care
|
||
Completed |
NCT02036840 -
Perioperative Antibiotic Choices for Surgical Prophylaxis in Penicillin-allergic Pediatric Patients
|
N/A | |
Terminated |
NCT00363688 -
Treating Patients With a History of Non-Life Threatening Allergic Reaction to Penicillin With Penicillin
|
Phase 4 | |
Completed |
NCT03158831 -
Drug Challenges Without Prior Skin Testing
|
Phase 1 | |
Recruiting |
NCT06303128 -
Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge
|
Phase 3 | |
Completed |
NCT03942731 -
Penicillin Allergy Testing and Resensitization Rate
|
||
Completed |
NCT05010304 -
Penicillin De-labeling in the Pediatric Primary Care Setting
|
Phase 4 | |
Completed |
NCT03404804 -
Oral Challenge in the Pediatric ED
|
Phase 4 |